Malcolm Kell
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- MicroRNA in disease regulation
- Oncology top 5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
Papers in
-
- Breast Cancer Treatment Studies 26
- Surgery 13
- Breast Implant and Reconstruction 10
- Reconstructive Surgery and Microvascular Techniques 7
- Co-authors
- Mitchel Barry (16 shared papers)Monica Morrow (3 shared papers)Michael J. Kerin (8 shared papers)John P. Burke (3 shared papers)Karl Sweeney (2 shared papers)Aoïfe Lowery (2 shared papers)Ronan W. Glynn (1 shared paper)Amanda McCann (6 shared papers)
- Journals
- British journal of surgery (7 papers)European Journal of Surgical Oncology (7 papers)Journal of Clinical Oncology (7 papers)Breast Cancer Research and Treatment (4 papers)The Breast Journal (3 papers)
- Partner nations
- IrelandUnited StatesAustralia
In The Last Decade
Malcolm Kell
65 papers receiving 2.2k citations
Malcolm Kell's Hit Papers
Peers
Comparison fields: 5 of 104
- Cancer Research 968
- Oncology 502
- Pathology and Forensic Medicine 324
- Surgery 462
- Pulmonary and Respiratory Medicine 232
Countries citing papers authored by Malcolm Kell
This map shows the geographic impact of Malcolm Kell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malcolm Kell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malcolm Kell more than expected).
Fields of papers citing papers by Malcolm Kell
This network shows the impact of papers produced by Malcolm Kell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malcolm Kell. The network helps show where Malcolm Kell may publish in the future.
Co-authors
The 25 scholars most cited alongside Malcolm Kell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The fate of chemoresistance in triple negative breast cancer (TNBC) Hit paper breakdown → | 2015 | 317 |
| 2 | 2011 | 298 | |
| 3 | 2009 | 232 | |
| 4 | 2011 | 195 | |
| 5 | 2015 | 139 | |
| 6 | 2013 | 122 | |
| 7 | 2000 | 71 | |
| 8 | 2010 | 64 | |
| 9 | 2011 | 58 | |
| 10 | 2004 | 51 | |
| 11 | 2012 | 46 | |
| 12 | 2005 | 45 | |
| 13 | 2013 | 44 | |
| 14 | 2017 | 41 | |
| 15 | 2007 | 37 | |
| 16 | 1999 | 37 | |
| 17 | 2006 | 34 | |
| 18 | 2010 | 31 | |
| 19 | 2007 | 29 | |
| 20 | 2011 | 28 |
About Malcolm Kell
Malcolm Kell is a scholar working on Cancer Research, Surgery, Pathology and Forensic Medicine, Oncology and Pulmonary and Respiratory Medicine, having authored 68 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (26 papers), Breast Lesions and Carcinomas (12 papers), Breast Implant and Reconstruction (10 papers), Reconstructive Surgery and Microvascular Techniques (7 papers), Immune Response and Inflammation (4 papers), BRCA gene mutations in cancer (3 papers), Cancer Diagnosis and Treatment (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (968 citations), Oncology (502 citations), Pathology and Forensic Medicine (324 citations), Surgery (462 citations) and Pulmonary and Respiratory Medicine (232 citations). Malcolm Kell has collaborated with scholars based in Ireland, United States and Australia. Frequent co-authors include Mitchel Barry, Monica Morrow, Michael J. Kerin, John P. Burke, Karl Sweeney, Aoïfe Lowery, Ronan W. Glynn, Amanda McCann, Luke Gubbins and Shiva Sharma. Their work appears in journals such as British journal of surgery, European Journal of Surgical Oncology, Journal of Clinical Oncology, Breast Cancer Research and Treatment and The Breast Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.